サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：鎮咳薬市場：薬剤クラス別、投与経路別、年齢層別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1339909

鎮咳薬市場：薬剤クラス別、投与経路別、年齢層別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測

Antitussive Drugs Market with COVID-19 Impact Analysis, By Drug Class, By Route of Administration, By Age Group, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 238 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
鎮咳薬市場：薬剤クラス別、投与経路別、年齢層別、エンドユーザー別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 238 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

鎮咳薬の市場規模は2022年に14億830万米ドルとなり、2023年から2030年にかけてCAGR 5.1％で拡大

鎮咳薬市場-市場力学：

  • 咳嗽患者の増加と老年人口の増加が市場成長を増大させる。
  • 鎮咳薬の需要を押し上げる主な要素は咳であり、これが市場成長を牽引します。さらに、呼吸器疾患の有病率の増加や大気汚染の高さにより、個人の咳の症例が増加しています。人々の咳や咳の伝染性は、世界中のプライマリケア医を訪れる最も一般的な目的です。このように、しつこい咳は人の生活の質を損なう可能性があるため、鎮咳薬の需要は堅調な伸びを示すと思われます。しかし、鎮咳薬の高価格と新興国市場におけるヘルスケアインフラの不足が市場需要の妨げになると予想されます。さらに、高齢者は慢性疾患にかかりやすく、市場の成長率を加速させると予想されます。そのため、高齢者人口の増加が市場を牽引すると予測されます。

鎮咳薬市場-セグメンテーション分析：

  • 世界の鎮咳薬市場は、薬剤クラス別、投与経路別、年齢層別、エンドユーザー別、地域別に区分されます。
  • 薬剤クラス別では、末梢性作用薬、中枢性作用薬、その他に分類されます。中枢作用薬セグメントは、予測期間中も優位性を維持すると思われます。咳中枢をターゲットとして脳に作用し、咳の衝動を最小限に抑えます。さらに、これらの薬剤は粘液を産生しない持続性の乾いた咳を治療するのに好まれています。市場を推進する要因としては、医薬品開発の進歩、ヘルスケア政策の変化、呼吸器疾患の流行、市販薬や処方薬に対する消費者の嗜好などが挙げられます。
  • 市場は投与経路によって、吸入、経口、その他の2つのカテゴリーに分けられます。経口剤が最も高い市場シェアを占めると予想されます。経口セグメントとは、錠剤、トローチ剤、シロップ剤、カプセル剤など、経口投与される鎮咳薬市場全体の中で、特定のセグメントの市場評価や分析を指します。
  • 市場は年齢層によって老人、小児、成人の3つに分類されます。高齢者向けセグメントは急速な成長が見込まれています。老年人口とは65歳以上を指します。老年人口には特別な医療ニーズや特徴があり、医薬品やヘルスケアなどいくつかの産業に影響を与えます。
  • 市場はエンドユーザーによって、在宅ケア、病院、専門クリニック、その他の3つのカテゴリーに分けられます。最大の市場シェアを占めるのは専門クリニックです。同セグメントは、呼吸器科や呼吸器内科など、特定の医療専門分野に焦点を当てています。専門クリニックは一般的に、呼吸器疾患に関する臨床試験や調査に従事しています。さらに、これは新しい鎮咳薬の試験と開発に役立ちます。

鎮咳薬市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

鎮咳薬市場-競合情勢：

鎮咳薬の入手のしやすさと認知度の向上は、市場成長に有利です。さらに、公的機関や民間団体が認知度を広めるためのイニシアチブを取ることで、鎮咳薬市場は盛り上がりを見せると思われます。上気道感染症の増加と可処分所得の増加が鎮咳薬ビジネスの拡大をもたらします。研究開発活動の増加は有益な機会を提供すると同時に、医薬品の上市や承認の増加が市場の成長率をさらに押し上げると思われます。例えば、2021年3月、メルク社は、米国食品医薬品局（FDA）が、原因不明の慢性咳嗽（UCC）または成人における難治性慢性咳嗽（RCC）の治療薬として開発中の治験薬、経口投与の選択的P2X3受容体拮抗薬、非麻薬薬であるgefapixantの新薬承認申請（NDA）に関して、次のステップについて協議するための審査完了報告書（CRL）を発行したと発表しました。

目次

第1章 鎮咳薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 鎮咳薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 鎮咳薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 鎮咳薬市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 鎮咳薬市場情勢

  • 鎮咳薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 鎮咳薬市場-薬剤クラス別

  • 概要
    • 薬剤クラス別のセグメントシェア分析
    • 末梢作用薬
    • 中枢作用薬
    • その他

第8章 鎮咳薬市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 吸入用
    • オーラル
    • その他

第9章 鎮咳薬市場- 年齢層別

  • 概要
    • 年齢層別セグメントシェア分析
    • 高齢者向け
    • 小児
    • アダルト

第10章 鎮咳薬市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • ホームケア
    • 病院
    • 専門クリニック
    • その他

第11章 鎮咳薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 鎮咳薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Intas Pharmaceuticals Ltd.
    • Bayer AG
    • Aceto
    • Sanofi
    • Ipca Laboratories Ltd.
    • 3M
    • F. Hoffmann-La Roche Ltd.
    • Hikma Pharmaceuticals PLC
    • Unique Pharmaceuticals Limited
    • Cipla Inc.
    • Mylan NV
    • Zydus Cadila
    • Sanofi
    • Novartis AG
    • Aurobindo Pharma

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antitussive Drugs Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Antitussive Drugs Market, by Drug Class2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Route of AdministrationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Antitussive Drugs Market, by Route of Administration2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Age Group Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global Antitussive Drugs Market, by Age Group 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: End-Users Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global Antitussive Drugs Market, by End-Users 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antitussive Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antitussive Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022&2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Age Group segment market share analysis, 2022&2030
  • FIGURE Age Groupsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Users segment market share analysis, 2022&2030
  • FIGURE End-Users segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Europe Antitussive Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Antitussive Drugs Market share and leading players, 2022
  • FIGURE Latin America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Antitussive Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Germany Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antitussive Drugs Market share analysis by country, 2022
  • FIGURE India Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Brazil Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1633

REPORT HIGHLIGHT

Antitussive drugs market size was valued at USD 1,408.3 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antitussive drugs are defined as heterogeneous medications commonly used in patients suffering from respiratory disorders to suppress dry cough. In addition, various symptoms caused by common allergies, colds, flu, hay fever, or other breathing disorders like bronchitis and sinusitis can be treated by antitussive drugs. These drugs act on the cough center in the brain to reduce the urge to cough in patients. They are either opioids or opiates such as dextromethorphan, pholcodine, and codeine. Moreover, one of the commonly used drugs is dextromethorphan over-the-counter antitussive drugs, and it is relatively safe.

Antitussive Drugs Market- Market Dynamics:

  • Rising cough cases and the geriatric population will augment the market growth.
  • The major element boosting demand for antitussive drugs is cough, which will drive the market growth. In addition, the growing prevalence of respiratory disorders and the high rate of atmospheric pollution increase the cases of cough in individuals. The contagious nature of people's coughs and coughs is the most common purpose to visit primary care physicians across the world. Thus, persistent cough can harm a person's quality of life; the demand for antitussive drugs will witness steady growth. However, the high cost of antitussive drugs and the lack of healthcare infrastructure in developing nations are expected to hamper the market demand. Furthermore, the older population is more prone to chronic disease, which is anticipated to accelerate the market's growth rate. Thus, the rise in the geriatric population will be projected to drive the market forward.

Antitussive Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global antitussive drugs market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)
  • The antitussive drugs industry has been witnessing steady growth due to the widespread occurrence of cough-related conditions, including respiratory infections, allergies, and chronic obstructive pulmonary disease (COPD). The demand for antitussive medications tends to spike during flu and cold seasons.
  • Based on drug class form segmentation, Centrally Acting Drugs was predicted to show promising market share in the year 2022
  • Some antitussive medications are combined with other active ingredients, such as decongestants or expectorants, to provide comprehensive relief from multiple cold and flu symptoms.

Antitussive Drugs Market- Segmentation Analysis:

  • The Global antitussive drugs market is segmented on the basis of drug class, route of administration, age group, end-users, and region.
  • The market is divided into two categories based on drug class: peripherally acting drugs, centrally acting drugs, and others. The centrally acting drugs segment is likely to maintain its dominance over the forecast period. It works in the brain by targeting the cough center, minimizing the urge to cough. Additionally, these medications are mostly preferred to treat persistent dry coughs that don't produce mucus. The factors propelling the market include advances in drug development, changes in healthcare policies, the prevalence of respiratory conditions, and consumer preferences for over-the-counter or prescription medications.
  • The market is divided into two categories based on the route of administration: inhalational, oral, and others. The oral segment is expected to hold the highest market share. It refers to a market assessment or analysis of a particular segment within the broader antitussive drugs market which are administered orally including tablets, lozenges, syrups, and capsules.
  • The market is divided into three categories based on age group: geriatric, pediatric, and adult. The geriatric segment is anticipated to witness speedy growth. The term geriatric population refers to individuals 65 and older. This population has special healthcare needs and traits that have implications for several industries, such as pharmaceuticals and healthcare.
  • The market is divided into three categories based on end-users: homecare, hospitals, specialty clinics, and others. The specialty clinics segment is likely to possess the largest market share. The segment focuses on selective medical specialties, including respiratory and pulmonology medicine. The clinics commonly engaged in clinical trials and research related to respiratory diseases. Additionally, this will assist in the testing and development of new antitussive drugs.

Antitussive Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antitussive Drugs Market- Competitive Landscape:

Easy availability and rising awareness of these drugs will offer advantages for market growth. Moreover, the antitussive drugs market will boost as public and private organizations take initiatives to spread awareness. Rising infection cases of the upper respiratory tract and high disposable income will result in the expansion of the antitussive drugs business. An increase in the number of research and development activities will provide beneficial opportunities as well as rising drug launches and approvals will further propel the market's growth rate. For instance, in March 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck's New Drug Application (NDA) for gefapixant, the investigational, orally administered selective P2X3 receptor antagonist, non-narcotic under development for the unexplained chronic cough (UCC) or treatment of refractory chronic cough (RCC) in adults agency to discuss the next steps.

Recent Developments:

For instance, in September 2021, Sun Pharmaceutical Industries Ltd. launched of a novel formulation in cough management - Chericof 12 (chlorpheniramine maleate 4 mg or dextromethorphan hydrobromide 30 mg) in India.

Key features of the study:

  • This proposed research study on antitussive drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the antitussive drugs market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for antitussive drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the antitussive drugs market.
  • Impact of COVID-19 on antitussive drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on antitussive drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the antitussive drugs market, we have also included competitive landscape and key innovator analysis for the antitussive drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the antitussive drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global antitussive drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTITUSSIVE DRUGS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Bayer AG
  • Aceto
  • Sanofi
  • Ipca Laboratories Ltd.
  • 3M
  • F. Hoffmann-La Roche Ltd.
  • Hikma Pharmaceuticals PLC
  • Unique Pharmaceuticals Limited
  • Cipla Inc.
  • Mylan N.V.
  • Zydus Cadila
  • Sanofi
  • Novartis AG
  • Aurobindo Pharma

GLOBAL ANTITUSSIVE DRUGS MARKET, BY DRUG CLASS

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY ROUTE OF ADMINISTRATION

  • Inhalational
  • Oral
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY AGE GROUP

  • Geriatric
  • Pediatric
  • Adult

GLOBAL ANTITUSSIVE DRUGS MARKET, BY END-USERS

  • Homecare
  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antitussive Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antitussive Drugs Market Snippet by Drug Class
    • 2.1.2. Antitussive Drugs Market Snippet by Route of Administration
    • 2.1.3. Antitussive Drugs Market Snippet by Age Group
    • 2.1.4. Antitussive Drugs Market Snippet by End-Users
    • 2.1.5. Antitussive Drugs Market Snippet by Country
    • 2.1.6. Antitussive Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Antitussive Drugs Key Market Trends

  • 3.1. Antitussive Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antitussive Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antitussive Drugs Market Opportunities
  • 3.4. Antitussive Drugs Market Future Trends

4. Antitussive Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antitussive Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antitussive Drugs Market Landscape

  • 6.1. Antitussive Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antitussive Drugs Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Peripherally Acting Drugs
    • 7.1.3. Centrally Acting Drugs
    • 7.1.4. Others

8. Antitussive Drugs Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 8.1.2. Inhalational
    • 8.1.3. Oral
    • 8.1.4. Others

9. Antitussive Drugs Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2022&2030 (%)
    • 9.1.2. Geriatric
    • 9.1.3. Pediatric
    • 9.1.4. Adult

10. Antitussive Drugs Market - By End-Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Users, 2022&2030 (%)
    • 10.1.2. Homecare
    • 10.1.3. Hospitals
    • 10.1.4. Specialty Clinics
    • 10.1.5. Others

11. Antitussive Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antitussive Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antitussive Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antitussive Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Antitussive Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Antitussive Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Antitussive Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Teva Pharmaceutical Industries Ltd.
    • 12.2.2. Intas Pharmaceuticals Ltd.
    • 12.2.3. Bayer AG
    • 12.2.4. Aceto
    • 12.2.5. Sanofi
    • 12.2.6. Ipca Laboratories Ltd.
    • 12.2.7. 3M
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Hikma Pharmaceuticals PLC
    • 12.2.10. Unique Pharmaceuticals Limited
    • 12.2.11. Cipla Inc.
    • 12.2.12. Mylan N.V.
    • 12.2.13. Zydus Cadila
    • 12.2.14. Sanofi
    • 12.2.15. Novartis AG
    • 12.2.16. Aurobindo Pharma

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us